TP53 and colorectal carcinoma: To investigate whether changes in the Stat3/p53/NFR2 axis are associated with pyroptosis and ferroptosis in CRC cells after GRh3 treatment, we pretreated CRC cells with PFT-α (a p53 inhibitor).